ANXA3 and ovarian cancer: Exosomes derived from chemoresistant cells show high expression of various resistance-related proteins, including MRP2, Annexin A3, ATP 7A, and ATP 7B; this clearly indicates the potential of exosomes to predict the efficacy of chemotherapy in ovarian cancer patients [92, 94].